Computational methods in drug discovery

The process for drug discovery and development is challenging, time consuming and expensive. Computer-aided drug discovery (CADD) tools can act as a virtual shortcut, assisting in the expedition of this long process and potentially reducing the cost of research and development. Today CADD has become an effective and indispensable tool in therapeutic development. The human genome project has made available a substantial amount of sequence data that can be used in various drug discovery projects. Additionally, increasing knowledge of biological structures, as well as increasing computer power have made it possible to use computational methods effectively in various phases of the drug discovery and development pipeline. The importance of in silico tools is greater than ever before and has advanced pharmaceutical research. Here we present an overview of computational methods used in different facets of drug discovery and highlight some of the recent successes. In this review, both structure-based and ligand-based drug discovery methods are discussed. Advances in virtual high-throughput screening, protein structure prediction methods, protein–ligand docking, pharmacophore modeling and QSAR techniques are reviewed.

[1]  R. Huddleston Structure , 2018, Jane Austen's Style.

[2]  Aboul Ella Hassanien,et al.  PQSAR: The membrane quantitative structure-activity relationships in cheminformatics , 2016, Expert Syst. Appl..

[3]  Kenji Mizuguchi,et al.  Integration of Ligand and Structure Based Approaches for CSAR-2014 , 2016, J. Chem. Inf. Model..

[4]  Yi Pan,et al.  HybridDock: A Hybrid Protein-Ligand Docking Protocol Integrating Protein- and Ligand-Based Approaches , 2016, J. Chem. Inf. Model..

[5]  Lei Liang,et al.  Development of novel proteasome inhibitors based on phthalazinone scaffold. , 2016, Bioorganic & medicinal chemistry letters.

[6]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.

[7]  Pratyush Tiwary,et al.  Prediction of Protein-Ligand Binding Poses via a Combination of Induced Fit Docking and Metadynamics Simulations. , 2016, Journal of chemical theory and computation.

[8]  J. Edwards,et al.  A Prospective Virtual Screening Study: Enriching Hit Rates and Designing Focus Libraries To Find Inhibitors of PI3Kδ and PI3Kγ. , 2016, Journal of medicinal chemistry.

[9]  Yi Wang,et al.  Simulation-Based Approaches for Determining Membrane Permeability of Small Compounds , 2016, J. Chem. Inf. Model..

[10]  Dong-Sheng Cao,et al.  ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting , 2016, J. Chem. Inf. Model..

[11]  J. Irwin,et al.  Docking Screens for Novel Ligands Conferring New Biology. , 2016, Journal of medicinal chemistry.

[12]  R. Siva,et al.  Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus , 2016, Infectious Diseases of Poverty.

[13]  Gustavo Henrique Goulart Trossini,et al.  Use of machine learning approaches for novel drug discovery , 2016, Expert opinion on drug discovery.

[14]  Jens Meiler,et al.  Improving quantitative structure–activity relationship models using Artificial Neural Networks trained with dropout , 2016, Journal of Computer-Aided Molecular Design.

[15]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[16]  Pedro J Ballester,et al.  Machine‐learning scoring functions to improve structure‐based binding affinity prediction and virtual screening , 2015, Wiley interdisciplinary reviews. Computational molecular science.

[17]  Chung F. Wong,et al.  Flexible receptor docking for drug discovery , 2015, Expert opinion on drug discovery.

[18]  A. Mazar,et al.  Virtual High-Throughput Screening To Identify Novel Activin Antagonists. , 2015, Journal of medicinal chemistry.

[19]  J. Andrew McCammon,et al.  Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation , 2015, Journal of chemical theory and computation.

[20]  Enrico Glaab,et al.  Building a virtual ligand screening pipeline using free software: a survey , 2015, Briefings Bioinform..

[21]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[22]  Rafael C. Bernardi,et al.  Enhanced sampling techniques in molecular dynamics simulations of biological systems. , 2015, Biochimica et biophysica acta.

[23]  Dima Kozakov,et al.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins , 2015, Nature Protocols.

[24]  Pei Tang,et al.  Ensemble-based virtual screening for cannabinoid-like potentiators of the human glycine receptor α1 for the treatment of pain. , 2015, Journal of medicinal chemistry.

[25]  Sonya M. Hanson,et al.  Capsaicin Interaction with TRPV1 Channels in a Lipid Bilayer: Molecular Dynamics Simulation , 2015, Biophysical journal.

[26]  Antonio Lavecchia,et al.  Machine-learning approaches in drug discovery: methods and applications. , 2015, Drug discovery today.

[27]  Jie Zhu,et al.  BEDAM binding free energy predictions for the SAMPL4 octa-acid host challenge , 2015, Journal of Computer-Aided Molecular Design.

[28]  Jie Liu,et al.  Classification of Current Scoring Functions , 2015, J. Chem. Inf. Model..

[29]  Sally R. Ellingson,et al.  Multi-conformer ensemble docking to difficult protein targets. , 2015, The journal of physical chemistry. B.

[30]  Ly Le,et al.  Identification of Novel Compounds against an R294K Substitution of Influenza A (H7N9) Virus Using Ensemble Based Drug Virtual Screening , 2015, International journal of medical sciences.

[31]  G. Ciccotti,et al.  Temperature‐accelerated molecular dynamics gives insights into globular conformations sampled in the free state of the AC catalytic domain , 2014, Proteins.

[32]  Christel A. S. Bergström,et al.  Computational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid , 2014, Pharmaceutical Research.

[33]  Felice C Lightstone,et al.  A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations. , 2014, Biophysical journal.

[34]  Haiyan Liu,et al.  Case study on temperature-accelerated molecular dynamics simulation of ligand dissociation: inducer dissociation from the Lac repressor protein. , 2014, The journal of physical chemistry. A.

[35]  Diane Joseph-McCarthy,et al.  Ensemble-Based Docking Using Biased Molecular Dynamics , 2014, J. Chem. Inf. Model..

[36]  J Andrew McCammon,et al.  Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site , 2014, Proceedings of the National Academy of Sciences.

[37]  Zhihai Liu,et al.  Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results , 2014, J. Chem. Inf. Model..

[38]  Pierre Tufféry,et al.  PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces , 2014, Nucleic Acids Res..

[39]  P Reddanna,et al.  Free energy calculations to estimate ligand-binding affinities in structure-based drug design. , 2014, Current pharmaceutical design.

[40]  W. Kühlbrandt The Resolution Revolution , 2014, Science.

[41]  Anna Tramontano,et al.  Critical assessment of methods of protein structure prediction (CASP) — round x , 2014, Proteins.

[42]  J. Mccammon,et al.  Exploring the role of receptor flexibility in structure-based drug discovery. , 2014, Biophysical chemistry.

[43]  Krzysztof Fidelis,et al.  CASP10 results compared to those of previous CASP experiments , 2014, Proteins.

[44]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[45]  Christoph Sommer,et al.  Machine learning in cell biology – teaching computers to recognize phenotypes , 2013, Journal of Cell Science.

[46]  J. Andrew McCammon,et al.  Accelerated Molecular Dynamics Simulations with the AMOEBA Polarizable Force Field on Graphics Processing Units , 2013, Journal of chemical theory and computation.

[47]  J. A. Gavira,et al.  Conservation of protein structure over four billion years. , 2013, Structure.

[48]  Robert J. Doerksen,et al.  Docking Challenge: Protein Sampling and Molecular Docking Performance , 2013, J. Chem. Inf. Model..

[49]  J Andrew McCammon,et al.  AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. , 2013, Journal of molecular graphics & modelling.

[50]  Andrzej Kolinski,et al.  CABS-fold: server for the de novo and consensus-based prediction of protein structure , 2013, Nucleic Acids Res..

[51]  J Andrew McCammon,et al.  Farnesyl Diphosphate Synthase Inhibitors from In Silico Screening , 2013, Chemical biology & drug design.

[52]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[53]  J. Mccammon,et al.  Accounting for Receptor Flexibility and Enhanced Sampling Methods in Computer‐Aided Drug Design , 2013, Chemical biology & drug design.

[54]  William Sinko,et al.  Antibacterial drug leads targeting isoprenoid biosynthesis , 2012, Proceedings of the National Academy of Sciences.

[55]  Carol Friedman,et al.  Drug-drug interaction through molecular structure similarity analysis , 2012, J. Am. Medical Informatics Assoc..

[56]  J Andrew McCammon,et al.  LigMerge: A Fast Algorithm to Generate Models of Novel Potential Ligands from Sets of Known Binders , 2012, Chemical biology & drug design.

[57]  Jian Peng,et al.  Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.

[58]  Yang Zhang,et al.  Ab initio protein structure assembly using continuous structure fragments and optimized knowledge‐based force field , 2012, Proteins.

[59]  Dima Kozakov,et al.  FTMAP: extended protein mapping with user-selected probe molecules , 2012, Nucleic Acids Res..

[60]  David Baker,et al.  Accurate protein structure modeling using sparse NMR data and homologous structure information , 2012, Proceedings of the National Academy of Sciences.

[61]  Ryan G. Coleman,et al.  ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..

[62]  P. Stewart,et al.  EM-fold: de novo atomic-detail protein structure determination from medium-resolution density maps. , 2012, Structure.

[63]  Haruki Nakamura,et al.  The Protein Data Bank at 40: reflecting on the past to prepare for the future. , 2012, Structure.

[64]  Thomas A. Hopf,et al.  Protein 3D Structure Computed from Evolutionary Sequence Variation , 2011, PloS one.

[65]  J. Kästner Umbrella sampling , 2011 .

[66]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[67]  Valery R. Polyakov,et al.  Web services as applications' integration tool: QikProp case study , 2011, J. Comput. Chem..

[68]  Grace W. Tang,et al.  Comparative modeling: the state of the art and protein drug target structure prediction. , 2011, Combinatorial chemistry & high throughput screening.

[69]  Roberto Sanchez,et al.  Beyond structural genomics: computational approaches for the identification of ligand binding sites in protein structures , 2011, Journal of Structural and Functional Genomics.

[70]  Luhua Lai,et al.  LigBuilder 2: A Practical de Novo Drug Design Approach , 2011, J. Chem. Inf. Model..

[71]  Alexander D. MacKerell,et al.  Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. , 2011, Current computer-aided drug design.

[72]  J. Meiler,et al.  RosettaEPR: an integrated tool for protein structure determination from sparse EPR data. , 2011, Journal of structural biology.

[73]  Mark McGann,et al.  FRED Pose Prediction and Virtual Screening Accuracy , 2011, J. Chem. Inf. Model..

[74]  Jacob D. Durrant,et al.  POVME: an algorithm for measuring binding-pocket volumes. , 2011, Journal of molecular graphics & modelling.

[75]  Haruki Nakamura,et al.  Prediction of ligand‐binding sites of proteins by molecular docking calculation for a random ligand library , 2011, Protein science : a publication of the Protein Society.

[76]  Wei Chen,et al.  Modeling Protein-Ligand Binding by Mining Minima. , 2010, Journal of chemical theory and computation.

[77]  J. Bajorath,et al.  Quo vadis, virtual screening? A comprehensive survey of prospective applications. , 2010, Journal of medicinal chemistry.

[78]  Xiaoqin Zou,et al.  Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. , 2010, Physical chemistry chemical physics : PCCP.

[79]  Thomas E. Exner,et al.  pKa based protonation states and microspecies for protein–ligand docking , 2010, J. Comput. Aided Mol. Des..

[80]  Nicolas Foloppe,et al.  Rigorous Free Energy Calculations in Structure‐Based Drug Design , 2010, Molecular informatics.

[81]  Emilio Gallicchio,et al.  The Binding Energy Distribution Analysis Method (BEDAM) for the Estimation of Protein-Ligand Binding Affinities. , 2010, Journal of chemical theory and computation.

[82]  Sheng-Yong Yang,et al.  Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.

[83]  E. Tajkhorshid,et al.  Exploring transmembrane diffusion pathways with molecular dynamics. , 2010, Physiology.

[84]  Mark Gerstein,et al.  3V: cavity, channel and cleft volume calculator and extractor , 2010, Nucleic Acids Res..

[85]  G. Ullmann,et al.  McVol - A program for calculating protein volumes and identifying cavities by a Monte Carlo algorithm , 2010, Journal of molecular modeling.

[86]  Jens Meiler,et al.  Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening , 2010, ACS chemical neuroscience.

[87]  Jitender Verma,et al.  3D-QSAR in drug design--a review. , 2010, Current topics in medicinal chemistry.

[88]  Chuan Wang,et al.  DescFold: A web server for protein fold recognition , 2009, BMC Bioinformatics.

[89]  Marianne A Grant,et al.  Protein structure prediction in structure-based ligand design and virtual screening. , 2009, Combinatorial chemistry & high throughput screening.

[90]  A. Elofsson,et al.  Structure is three to ten times more conserved than sequence—A study of structural response in protein cores , 2009, Proteins.

[91]  J. P. Grossman,et al.  Millisecond-scale molecular dynamics simulations on Anton , 2009, Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis.

[92]  M. Jacobson,et al.  Automated site preparation in physics‐based rescoring of receptor ligand complexes , 2009, Proteins.

[93]  P. Stewart,et al.  EM-fold: De novo folding of alpha-helical proteins guided by intermediate-resolution electron microscopy density maps. , 2009, Structure.

[94]  Claudio N. Cavasotto,et al.  Homology modeling in drug discovery: current trends and applications. , 2009, Drug discovery today.

[95]  William L Jorgensen,et al.  Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.

[96]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[97]  Yongbo Hu,et al.  Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..

[98]  Dario Ghersi,et al.  SITEHOUND-web: a server for ligand binding site identification in protein structures , 2009, Nucleic Acids Res..

[99]  L. Dawson,et al.  A Method for the Measurement of Shielding Effectiveness of Planar Samples Requiring No Sample Edge Preparation or Contact , 2009, IEEE Transactions on Electromagnetic Compatibility.

[100]  Samo Turk,et al.  Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB). , 2009, Bioorganic & medicinal chemistry letters.

[101]  Thomas A. Halgren,et al.  Identifying and Characterizing Binding Sites and Assessing Druggability , 2009, J. Chem. Inf. Model..

[102]  E. V. Name,et al.  High-Potency Olfactory Receptor Agonists Discovered by Virtual High-Throughput Screening: Molecular Probes for Receptor Structure and Olfactory Function , 2008, Neuron.

[103]  A. Laio,et al.  Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science , 2008 .

[104]  Colin W. G. Fishwick,et al.  Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase , 2008 .

[105]  J. Nosanchuk,et al.  Biological Function and Molecular Mapping of M Antigen in Yeast Phase of Histoplasma capsulatum , 2008, PloS one.

[106]  J. Essex,et al.  Hit identification and binding mode predictions by rigorous free energy simulations. , 2008, Journal of medicinal chemistry.

[107]  E. Carpenter,et al.  Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.

[108]  Olivier Sperandio,et al.  FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects , 2008, BMC Bioinformatics.

[109]  D. Hazuda,et al.  Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. , 2008, Journal of medicinal chemistry.

[110]  Sitao Wu,et al.  MUSTER: Improving protein sequence profile–profile alignments by using multiple sources of structure information , 2008, Proteins.

[111]  J. Meiler,et al.  A model for the solution structure of the rod arrestin tetramer. , 2008, Structure.

[112]  William L Jorgensen,et al.  Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria. , 2008, Journal of chemical theory and computation.

[113]  Mark Johnson,et al.  NCBI BLAST: a better web interface , 2008, Nucleic Acids Res..

[114]  Markus Ringnér,et al.  What is principal component analysis? , 2008, Nature Biotechnology.

[115]  Natalia Artemenko,et al.  Distance Dependent Scoring Function for Describing Protein-Ligand Intermolecular Interactions , 2008, J. Chem. Inf. Model..

[116]  Jens Meiler,et al.  De novo high-resolution protein structure determination from sparse spin-labeling EPR data. , 2008, Structure.

[117]  Reiji Teramoto,et al.  Consensus Scoring with Feature Selection for Structure-Based Virtual Screening , 2008, J. Chem. Inf. Model..

[118]  Yang Zhang,et al.  I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.

[119]  Nikhil S. Ketkar,et al.  High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods. , 2008, Journal of medicinal chemistry.

[120]  M. Parrinello,et al.  Well-tempered metadynamics: a smoothly converging and tunable free-energy method. , 2008, Physical review letters.

[121]  Rommie E. Amaro,et al.  An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..

[122]  Istvan J. Enyedy,et al.  Can we use docking and scoring for hit-to-lead optimization? , 2008, J. Comput. Aided Mol. Des..

[123]  D. Kern,et al.  Dynamic personalities of proteins , 2007, Nature.

[124]  William L Jorgensen,et al.  From docking false-positive to active anti-HIV agent. , 2007, Journal of medicinal chemistry.

[125]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[126]  Dietmar Schomburg,et al.  Efficient comprehensive scoring of docked protein complexes using probabilistic support vector machines , 2007, Proteins.

[127]  Wolfgang Wenzel,et al.  Receptor‐specific scoring functions derived from quantum chemical models improve affinity estimates for in‐silico drug discovery , 2007, Proteins.

[128]  Andrzej Kolinski,et al.  Protein structure prediction: Combining de novo modeling with sparse experimental data , 2007, J. Comput. Chem..

[129]  L. Jong,et al.  Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling. , 2007, Journal of medicinal chemistry.

[130]  Richard A. Friesner,et al.  Comparative Performance of Several Flexible Docking Programs and Scoring Functions: Enrichment Studies for a Diverse Set of Pharmaceutically Relevant Targets , 2007, J. Chem. Inf. Model..

[131]  Sorin Draghici,et al.  Machine Learning and Its Applications to Biology , 2007, PLoS Comput. Biol..

[132]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[133]  T. Schwede,et al.  Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach , 2007, Molecular Pharmacology.

[134]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[135]  SHENG-YOU HUANG,et al.  An iterative knowledge‐based scoring function to predict protein–ligand interactions: I. Derivation of interaction potentials , 2006, J. Comput. Chem..

[136]  Jens Meiler,et al.  ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility , 2006, Proteins.

[137]  M. Jacobson,et al.  Molecular mechanics methods for predicting protein-ligand binding. , 2006, Physical chemistry chemical physics : PCCP.

[138]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[139]  David M. Ferguson,et al.  A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist , 2006, J. Comput. Aided Mol. Des..

[140]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using Modeller , 2006, Current protocols in bioinformatics.

[141]  D. E. Clark What has computer-aided molecular design ever done for drug discovery? , 2006, Expert opinion on drug discovery.

[142]  Z. Xiang,et al.  Advances in homology protein structure modeling. , 2006, Current protein & peptide science.

[143]  Xueliang Fang,et al.  Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. , 2006, Journal of medicinal chemistry.

[144]  Tudor I. Oprea,et al.  Virtual and biomolecular screening converge on a selective agonist for GPR30 , 2006, Nature chemical biology.

[145]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[146]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[147]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[148]  Hu Mei,et al.  Support vector machine applied in QSAR modelling , 2005 .

[149]  P. Bradley,et al.  Toward High-Resolution de Novo Structure Prediction for Small Proteins , 2005, Science.

[150]  G. Klebe,et al.  DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. , 2005, Journal of medicinal chemistry.

[151]  刘金明,et al.  IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .

[152]  Johannes Söding,et al.  The HHpred interactive server for protein homology detection and structure prediction , 2005, Nucleic Acids Res..

[153]  S. Gupta,et al.  A quantitative structure–activity relationship study on some aromatic/heterocyclic sulfonamides and their charged derivatives acting as carbonic anhydrase inhibitors , 2005, Journal of enzyme inhibition and medicinal chemistry.

[154]  M. Karplus,et al.  Molecular dynamics and protein function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Richard M. Jackson,et al.  Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites , 2005, Bioinform..

[156]  Christel A. S. Bergström,et al.  In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. , 2005, Basic & clinical pharmacology & toxicology.

[157]  John B. O. Mitchell,et al.  Predicting protein-ligand binding affinities: a low scoring game? , 2004, Organic & biomolecular chemistry.

[158]  Didier Rognan,et al.  Comparative evaluation of eight docking tools for docking and virtual screening accuracy , 2004, Proteins.

[159]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[160]  Shaomeng Wang,et al.  An Extensive Test of 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein-Ligand Complexes , 2004, J. Chem. Inf. Model..

[161]  Mark Embrey,et al.  A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[162]  W Patrick Walters,et al.  A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance , 2004, Proteins.

[163]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[164]  J. Mongan,et al.  Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules. , 2004, The Journal of chemical physics.

[165]  D. J. Price,et al.  Assessing scoring functions for protein-ligand interactions. , 2004, Journal of medicinal chemistry.

[166]  J Andrew McCammon,et al.  Discovery of a novel binding trench in HIV integrase. , 2004, Journal of medicinal chemistry.

[167]  W. L. Jorgensen The Many Roles of Computation in Drug Discovery , 2004, Science.

[168]  Daisuke Takaya,et al.  Protein structure prediction in structure based drug design. , 2004, Current medicinal chemistry.

[169]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[170]  Kenji Mizuguchi,et al.  Fold recognition for drug discovery , 2004 .

[171]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[172]  J. Skolnick,et al.  TOUCHSTONEX: Protein structure prediction with sparse NMR data , 2003, Proteins.

[173]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[174]  Jens Meiler,et al.  Epothilones: Quantitative Structure Activity Relations Studied by Support Vector Machines and Artificial Neural Networks , 2003 .

[175]  Jens Sadowski,et al.  Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..

[176]  A. Anderson The process of structure-based drug design. , 2003, Chemistry & biology.

[177]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[178]  Dawen Gao,et al.  A Study on Prediction of the Bio‐toxicity of Substituted Benzene Based on Artificial Neural Network , 2003, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[179]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[180]  Satya P. Gupta Quantitative structure-activity relationships of renin inhibitors. , 2003, Mini reviews in medicinal chemistry.

[181]  D. Fabbro,et al.  Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. , 2003, Journal of medicinal chemistry.

[182]  Thierry Langer,et al.  Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. , 2003, Current opinion in drug discovery & development.

[183]  C. Kontogiorgis,et al.  Quantitative structure -- activity relationships (QSARs) of thrombin inhibitors: review, evaluation and comparative analysis. , 2003, Current medicinal chemistry.

[184]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[185]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[186]  Martin Stahl,et al.  Binding site characteristics in structure-based virtual screening: evaluation of current docking tools , 2003, Journal of molecular modeling.

[187]  G. Klebe,et al.  Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. , 2002, Angewandte Chemie.

[188]  Andrew R. Leach,et al.  A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP , 2002, J. Comput. Aided Mol. Des..

[189]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[190]  M. Hashida,et al.  Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. , 2002, International journal of pharmaceutics.

[191]  Z. Luthey-Schulten,et al.  Ab initio protein structure prediction. , 2002, Current opinion in structural biology.

[192]  Bernard F. Buxton,et al.  Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..

[193]  F. Jørgensen,et al.  A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. , 2001, Journal of medicinal chemistry.

[194]  A. Good,et al.  3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.

[195]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[196]  D. Baker,et al.  Prospects for ab initio protein structural genomics. , 2001, Journal of molecular biology.

[197]  M Rarey,et al.  Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.

[198]  D. Baker,et al.  De novo protein structure determination using sparse NMR data , 2000, Journal of biomolecular NMR.

[199]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[200]  Luhua Lai,et al.  LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design , 2000 .

[201]  Uko Maran,et al.  Non-Linear QSAR Treatment of Genotoxicity , 2000 .

[202]  Shu-Kun Lin Pharmacophore Perception, Development and Use in Drug Design. Edited by Osman F. Güner , 2000 .

[203]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[204]  G. Klebe,et al.  Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.

[205]  Thomas Lengauer,et al.  Protein Structure Prediction Methods for Drug Design , 2000, Briefings Bioinform..

[206]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[207]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[208]  Thomas Lengauer,et al.  Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking , 1999, Proteins.

[209]  Janet M. Thornton,et al.  BLEEP—potential of mean force describing protein–ligand interactions: I. Generating potential , 1999 .

[210]  Andrew E. Torda,et al.  The GROMOS biomolecular simulation program package , 1999 .

[211]  David C. Jones,et al.  GenTHREADER: an efficient and reliable protein fold recognition method for genomic sequences. , 1999, Journal of molecular biology.

[212]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[213]  Dale J. Kempf,et al.  ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease , 1998, Antimicrobial Agents and Chemotherapy.

[214]  Luhua Lai,et al.  SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex , 1998 .

[215]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[216]  A. Sali,et al.  Large-scale protein structure modeling of the Saccharomyces cerevisiae genome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[217]  J. Skolnick,et al.  Assembly of protein structure from sparse experimental data: An efficient Monte Carlo model , 1998, Proteins.

[218]  D. Fischer,et al.  Assigning folds to the proteins encoded by the genome of Mycoplasma genitalium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[219]  T. Kennedy Managing the drug discovery/development interface , 1997 .

[220]  J. Stürzebecher,et al.  Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine. , 1997, Journal of medicinal chemistry.

[221]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[222]  C Kooperberg,et al.  Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. , 1997, Journal of molecular biology.

[223]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[224]  M. Swindells,et al.  Protein clefts in molecular recognition and function. , 1996, Protein science : a publication of the Protein Society.

[225]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[226]  M. Wolff,et al.  BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY , 1996 .

[227]  S. Wodak,et al.  Protein structure prediction by threading methods: Evaluation of current techniques , 1995, Proteins.

[228]  R. Glen,et al.  Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties. , 1995, Journal of medicinal chemistry.

[229]  A. N. Jain,et al.  Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. , 1994, Journal of medicinal chemistry.

[230]  Hans-Joachim Böhm,et al.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..

[231]  Peter A. Kollman,et al.  FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .

[232]  H. Villar,et al.  Strategies for Indirect Computer-Aided Drug Design , 1993, Pharmaceutical Research.

[233]  D. Wortham,et al.  Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. , 1993, JAMA.

[234]  D. T. Jones,et al.  A new approach to protein fold recognition , 1992, Nature.

[235]  Gilles Klopmand,et al.  Concepts and applications of molecular similarity, by Mark A. Johnson and Gerald M. Maggiora, eds., John Wiley & Sons, New York, 1990, 393 pp. Price: $65.00 , 1992 .

[236]  J S Mills,et al.  Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase. , 1991, Antiviral research.

[237]  P. Timmermans,et al.  The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. , 1990, Journal of medicinal chemistry.

[238]  John P. Overington,et al.  Knowledge‐based protein modelling and design , 1988 .

[239]  R Langridge,et al.  A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitors. , 1985, Molecular pharmacology.

[240]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[241]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[242]  Peter A. Kollman,et al.  AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions , 1981 .

[243]  H. Koga,et al.  Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. , 1980, Journal of medicinal chemistry.

[244]  A. Lesk,et al.  How different amino acid sequences determine similar protein structures: the structure and evolutionary dynamics of the globins. , 1980, Journal of molecular biology.

[245]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.

[246]  G. Torrie,et al.  Nonphysical sampling distributions in Monte Carlo free-energy estimation: Umbrella sampling , 1977 .

[247]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[248]  R. Zwanzig High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .

[249]  W. Snodgrass Physiology , 1897, Nature.

[250]  Wilfrido Moreno,et al.  Introduction to Artificial Neural Network (ANN) as a Predictive Tool for Drug Design, Discovery, Delivery, and Disposition , 2016 .

[251]  S. Singh,et al.  Application of Artificial Neural Networks in Modern Drug Discovery Chapter – 6 published in Artificial Neural Network for Drug Design, Delivery and Disposition , 2015 .

[252]  Alexander D. MacKerell,et al.  Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design. , 2015, Methods in molecular biology.

[253]  Steffen Lindert,et al.  In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors , 2014, Journal of Computer-Aided Molecular Design.

[254]  Christophe Chipot,et al.  Frontiers in free‐energy calculations of biological systems , 2014 .

[255]  Santiago Vilar,et al.  Application of Monte Carlo-based receptor ensemble docking to virtual screening for GPCR ligands. , 2013, Methods in enzymology.

[256]  Riccardo Baron,et al.  Computational Drug Discovery and Design , 2012, Methods in Molecular Biology.

[257]  Jin Wang,et al.  Pocket-Based Drug Design: Exploring Pocket Space , 2012, The AAPS Journal.

[258]  J Andrew McCammon,et al.  A molecular dynamics ensemble-based approach for the mapping of druggable binding sites. , 2012, Methods in molecular biology.

[259]  J Andrew McCammon,et al.  Accelerated molecular dynamics in computational drug design. , 2012, Methods in molecular biology.

[260]  V. Vyas,et al.  Homology Modeling a Fast Tool for Drug Discovery: Current Perspectives , 2012, Indian journal of pharmaceutical sciences.

[261]  Rizi Ai,et al.  Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use. , 2012, Methods in molecular biology.

[262]  Matthias Rarey,et al.  A consistent description of HYdrogen bond and DEhydration energies in protein–ligand complexes: methods behind the HYDE scoring function , 2012, Journal of Computer-Aided Molecular Design.

[263]  Jürgen Bajorath,et al.  Chemoinformatics and Computational Chemical Biology , 2011, Methods in Molecular Biology.

[264]  Klaus Schulten,et al.  Implementation of Accelerated Molecular Dynamics in NAMD. , 2011, Computational science & discovery.

[265]  Jinbo Xu,et al.  Raptorx: Exploiting structure information for protein alignment by statistical inference , 2011, Proteins.

[266]  Santosh A. Khedkar,et al.  Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. , 2010, Current topics in medicinal chemistry.

[267]  David L. Mobley,et al.  Drug Design: Free-energy calculations in structure-based drug design , 2010 .

[268]  Rommie E. Amaro,et al.  Emerging methods for ensemble-based virtual screening. , 2010, Current topics in medicinal chemistry.

[269]  Kenneth M. Merz,et al.  Drug Design : Structure-and Ligand-Based Approaches , 2017 .

[270]  Daniel J. Rigden,et al.  From Protein Structure to Function with Bioinformatics , 2009 .

[271]  Sitao Wu,et al.  Ab Initio Protein Structure Prediction , 2009 .

[272]  Corwin Hansch,et al.  Camptothecins: a SAR/QSAR study. , 2009, Chemical reviews.

[273]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[274]  T. Schwede,et al.  Protein structure homology modeling using SWISS-MODEL workspace , 2008, Nature Protocols.

[275]  J. Leroux,et al.  Predicting the Solubility of the Anti-Cancer Agent Docetaxel in Small Molecule Excipients using Computational Methods , 2007, Pharmaceutical Research.

[276]  Jin Li,et al.  On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..

[277]  David C Fry,et al.  Protein-protein interactions as targets for small molecule drug discovery. , 2006, Biopolymers.

[278]  GuanHua Chen,et al.  A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.

[279]  I. Tetko,et al.  In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. , 2006, Current medicinal chemistry.

[280]  Shuichi Hirono,et al.  Comparison of Consensus Scoring Strategies for Evaluating Computational Models of Protein-Ligand Complexes , 2006, J. Chem. Inf. Model..

[281]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[282]  ScienceDirect Drug discovery today. Targets , 2004 .

[283]  BMC Biology , 2004 .

[284]  Beat Ernst,et al.  Drug discovery today. , 2003, Current topics in medicinal chemistry.

[285]  C. Venkatachalam,et al.  LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.

[286]  Jens Meiler,et al.  Rosetta predictions in CASP5: Successes, failures, and prospects for complete automation , 2003, Proteins.

[287]  Jung-Hsin Lin,et al.  The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme. , 2003, Biopolymers.

[288]  Luhua Lai,et al.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..

[289]  M J Sternberg,et al.  Enhancement of protein modeling by human intervention in applying the automatic programs 3D‐JIGSAW and 3D‐PSSM , 2001, Proteins.

[290]  S. Ekins,et al.  Application of in silico approaches to predicting drug--drug interactions. , 2001, Journal of pharmacological and toxicological methods.

[291]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[292]  M. Murcko,et al.  Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme , 1995 .

[293]  T L Blundell,et al.  Protein structure--based drug design. , 1994, Annual review of biophysics and biomolecular structure.

[294]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.